Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension

被引：3
|
作者：
Miura, Yohei [1 ]
Kataoka, Masaharu [3 ]
Chiba, Tomohiro [2 ]
Inami, Takumi [1 ]
Yoshino, Hideaki [1 ]
Satoh, Toru [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan
来源：
CIRCULATION JOURNAL | 2018年 / 82卷 / 10期
关键词：
Epoprostenol; Giant fold gastritis; Pulmonary arterial hypertension; Stomach barium examination; THERAPY;
D O I：
10.1253/circj.CJ-18-0349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Epoprostenol infusion is the strongest and most convincing therapeutic strategy for severe pulmonary arterial hypertension (PAH). This study investigated the gastrointestinal side effects of epoprostenol. Methods and Results: The study group of 12 patients treated with epoprostenol (epoprostenol group) and 4 patients without epoprostenol (control group) underwent stomach barium examination, which revealed that the prevalence of giant fold gastritis was significantly higher in the patients treated with epoprostenol (75% in epoprostenol group vs. 0% in control group; P=0.019). Conclusions: Giant fold gastritis may be an important side effect of epoprostenol infusion.
引用
收藏
页码：2676 / 2677
页数：2
相关论文
共 50 条
  • [21] Low Incidence of Catheter-Related Complications in Patients With Advanced Pulmonary Arterial Hypertension Undergoing Continuous Epoprostenol Infusion
    Nagai, Toshiyuki
    Kohsaka, Shun
    Anzai, Toshihisa
    Yoshikawa, Tsutomu
    Fukuda, Keiichi
    Sato, Toru
    CHEST, 2012, 141 (01) : 272 - 273
  • [22] Long-Term Epoprostenol Infusion Therapy Could Induce Hyperthyroidism in Patients With Idiopathic and Hereditary Pulmonary Arterial Hypertension
    Funasako, Moritoshi
    Miyaji, Katsumasa
    Sakuma, Masahito
    Takagi, Yaemi
    Kyotani, Shingo
    Nakanishi, Norifumi
    CIRCULATION, 2010, 122 (21)
  • [23] A new epoprostenol formulation for the treatment of pulmonary arterial hypertension
    Fuentes, Amaris
    Coralic, Aida
    Dawson, Kyle L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (16) : 1389 - 1393
  • [24] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
    M J Garabedian
    W F Hansen
    E A Gianferrari
    K Y Lain
    R Y Fragneto
    C L Campbell
    D C Booth
    Journal of Perinatology, 2010, 30 : 628 - 631
  • [25] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
    Garabedian, M. J.
    Hansen, W. F.
    Gianferrari, E. A.
    Lain, K. Y.
    Fragneto, R. Y.
    Campbell, C. L.
    Booth, D. C.
    JOURNAL OF PERINATOLOGY, 2010, 30 (09) : 628 - 631
  • [26] Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Greig, Sarah L.
    Scott, Lesley J.
    Plosker, Greg L.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (06) : 463 - 470
  • [27] Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
    Chebib, Nader
    Cottin, Vincent
    Taharo-Ag-Ralissoum, Martine
    Chuzeville, Michel
    Mornex, Jean-Francois
    PULMONARY CIRCULATION, 2018, 8 (01)
  • [28] Epoprostenol (Veletri®, Caripul®): A Review of Its Use in Patients with Pulmonary Arterial Hypertension
    Sarah L. Greig
    Lesley J. Scott
    Greg L. Plosker
    American Journal of Cardiovascular Drugs, 2014, 14 : 463 - 470
  • [29] Epoprostenol-associated ascites in pulmonary arterial hypertension
    Schoenberg, Noah C.
    Ruopp, Nicole F.
    Parikh, Raj D.
    Farber, Harrison W.
    PULMONARY CIRCULATION, 2022, 12 (02)
  • [30] Endothelin-1 (ET-1) across the Lung Circulation in Patients with Pulmonary Arterial Hypertension and Influence of Epoprostenol Infusion
    Selimovic, N.
    Bergh, C. -H.
    Anderson, B.
    Sakiniene, E.
    Carlsten, H.
    Rundqvist, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S203 - S204
12345